Keywords: بوسنتان; Graft co-polymer; Soluplus®; Nanocomposite; Bosentan; Solubility and bioavailability;
مقالات ISI بوسنتان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بوسنتان; bosentan; newborn; persistent pulmonary hypertension;
Keywords: بوسنتان; 2D-sw; 2D-sandwich; AMI; amiodarone; APAP; acetaminophen; BA; bile acid; BC; bile canaliculi; BOS; bosentan; BSEP; bile salt export pump; CPZ; chlorpromazine; CSA; cyclosporine A; CYP450; cytochrome P450; DIC; drug-induced cholestasis; DICI; drug-induced
Keywords: بوسنتان; Oral cancer; Bosentan; Morphine; Pain management; Rats;
Keywords: بوسنتان; Dry powder inhalers; Carrier; Lactose; Particle image velocimetry; Bosentan;
Keywords: بوسنتان; Ambrisentan (PubChem CID: 6918493); bosentan sodium (PubChem CID: 44387533); endothelin-1 (PubChem CID: 16132423); and macitentan (PubChem CID: 16004692); Endothelin-1; ET1-receptors; Ambrisentan; Bosentan; Macitentan; Human radial artery; Human pulmonary
Keywords: بوسنتان; Hypoxemia; Nitric oxide; Sildenafil; Milrinone; Prostacyclin; Bosentan;
Keywords: بوسنتان; bosentan; clinical trial; endothelin; heart failure; placebo; CI; confidence interval(s); ETA; endothelin type A; HR; hazard ratio(s);
Keywords: بوسنتان; Systemic sclerosis; Digital ulcers; Hand; Disability; Bosentan;
Keywords: بوسنتان; Bosentan; Zinc complex; Crystal structure; Potentiometry; Protonation and stability constants; Thermodynamic parameters;
Keywords: بوسنتان; Solubility; Bosentan; Solution thermodynamics; Preferential solvation; Jouyban-Acree model; Ethanol;
Keywords: بوسنتان; G protein coupled receptors; Endothelin; ETA; ETB; Biased agonism; Biased antagonism; β-Arrestin; Bosentan; Pathway selectivity; IRL1620;
Keywords: بوسنتان; Hypoxia; Oxygen; Nitric oxide; Prostacyclin; Sildenafil; Bosentan; Iloprost; Milrinone;
Keywords: بوسنتان; Bosentan; Perfluorinated analogues; Metabolic specificity; Phase I metabolism; HLM; Cl; Clearance; CYP; Cytochrome P450; DDI; drug-drug interactions; ERA; Endothelin Receptor Antagonist; ET-1; Endothelin 1; ETA; Endothelin receptor A; ETB; Endothelin rece
Keywords: بوسنتان; Bosentan; Sarcoidosis; Pulmonary hypertension; Dyspnea;
Keywords: بوسنتان; Pulmonary hypertension; Choroidal melanoma; Endothelin; Bosentan;
Keywords: بوسنتان; Chronic thromboembolic pulmonary hypertension; Pulmonary arterial hypertension; Advanced therapy; Bosentan; Endothelin receptor antagonist;
Keywords: بوسنتان; Bosentan; Endothelin; Depression; Cytokine;
Keywords: بوسنتان; Bosentan; Glimepiride; UPLC–MS/MS; Human plasma; Pharmacokinetic study
Keywords: بوسنتان; Bosentan; Ambrisentan; Sildenafil; Tadalafil; LC–MS/MS
Keywords: بوسنتان; Diabetes; Vascular remodeling; Endothelin; Metformin; Bosentan; Neovascularization;
Keywords: بوسنتان; 6-minute walk distance; bosentan; hyperuricemia; pulmonary arterial hypertension; sitaxentan; uric acid;
Keywords: بوسنتان; Pulmonary arterial hypertension; Segmental; Bosentan; Congenital heart disease;
Keywords: بوسنتان; Endothelial progenitor cells; Endothelin-1; Diabetes; Vascular diseases; Bosentan;
Keywords: بوسنتان; Bosentan; Ischaemia/reperfusion; Ovarian; Oxidative stress; Endothelin;
QBD-based systematic development of BosentanSNEDDS: Formulation, characterization and pharmacokinetic assessment
Keywords: بوسنتان; Bosentan; Self-emulsifying drug delivery system; Quality by design; Central composite design; Pharmacokinetic study;
CHST3 and CHST13 polymorphisms as predictors of bosentan-induced liver toxicity in Japanese patients with pulmonary arterial hypertension
Keywords: بوسنتان; Bosentan; Pulmonary arterial hypertension; Proteoglycan; DMET; Asian; Drug metabolism enzymes and transporters; Affimetrix; Pharmacogenomics; Pharmacogenetics;
Evaluation of the effects of RP5063, a novel, multimodal, serotonin receptor modulator, as single-agent therapy and co-administrated with sildenafil, bosentan, and treprostinil in a monocrotaline-induced pulmonary arterial hypertension rat model
Keywords: بوسنتان; Bosentan; Pulmonary arterial hypertension; RP5063; 5-Hydroxytryptamine 2B receptor; Sildenafil; Treprostinil;
A case of anti-aminoacyl tRNA synthetase (ARS) antibody-positive polymyositis (PM)/dermatomyositis (DM)-associated interstitial pneumonia (IP) successfully controlled with bosentan therapy
Keywords: بوسنتان; Bosentan; Endothelin antagonist; Interstitial pneumonia; Pulmonary hypertension; Collagen-vascular disease; ADM; amyopathic dermatomyositis; ASS; anti-synthetase syndrome; CVD; collagen-vascular disease; IP; interstitial pneumonia; PAP; pulmonary artery p
Physicochemical, thermodynamic and analytical studies on binary and ternary inclusion complexes of bosentan with hydroxypropyl-β-cyclodextrin
Keywords: بوسنتان; Bosentan; Hydroxypropyl-β-cyclodextrin; Physicochemical; Inclusion complex; Thermodynamic; Analytical;
FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion
Keywords: بوسنتان; Bosentan; Pediatric; Pulmonary arterial hypertension; Safety;
A model analysis for dose-response relationship of warfarin in Japanese children: An introduction of the SIZE parameter
Keywords: بوسنتان; Warfarin; Growth and development; Japanese pediatric patients; VKORC1; Bosentan;
Both cholestatic and steatotic drugs trigger extensive alterations in the mRNA level of biliary transporters in rat hepatocytes: Application to develop new predictive biomarkers for early drug development
Keywords: بوسنتان; ANIT; α-Naphthyl isothiocyanate; AMIK; amikacin; AMIO; amiodarone hydrochloride; AMIT; amitriptyline; AUC; area under the curve; AZAT; azathioprine; BA; bile acid; BOSE; Bosentan; C; cholestatic drug; CHLO; chlorpromazine; CITR; citrate; CYCA; cyclospori
Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis
Keywords: بوسنتان; Bosentan; Endothelin antagonist; Idiopathic pulmonary fibrosis; Pulmonary hypertension; Respiratory failurePAP, pulmonary artery pressure; PH, pulmonary hypertension; IPF, idiopathic pulmonary fibrosis
Endothelin Receptors and Their Antagonists
Keywords: بوسنتان; Ambrisentan; antagonist; bosentan; endothelin-1; macitentan; sitaxentan;
Development and validation of UFLC–MS/MS method for determination of bosentan in rat plasma
Keywords: بوسنتان; Bosentan; UFLC–MS/MS; Rat plasma; Validation; Liquid-liquid extraction
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients
Keywords: بوسنتان; Endothelin; Pulmonary arterial hypertension; Risk factors; Survival; Bosentan;
Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats
Keywords: بوسنتان; ET; endothelin; NAC; N-acetylcysteine; PBS; phosphate buffered saline; TNF-α; tumor necrosis factor-α; ALT; alanine aminotransferase; AST; aspartate aminotransferase; SOD; Superoxide dismutases; GSH; Glutathione; MDA; Malondialdehyde; NAPQI; N- asetil-
Myocardial and antiâinflammatory effects of chronic bosentan therapy in monocrotalineâinduced pulmonary hypertension
Keywords: بوسنتان; Pulmonary hypertension; Endothelinâ1 antagonists; Right ventricular function; Bosentan; Hipertensão pulmonar; Antagonistas da endotelinaâ1; Função ventricular direita; Bosentan;
Hepatotoxicidad en pacientes tratados con antagonistas del receptor de la endotelina: revisión sistemática y metaanálisis de ensayos clÃnicos aleatorizados
Keywords: بوسنتان; Bosentán; Ambrisentán; Sitaxentán; Sitaxsentán; Ensayo clÃnico aleatorizado y controlado; Metaanálisis; Reacción hepática; Hepatotoxicidad; Daño hepático; Bosentan; Ambrisentan; Sitaxentan; Sitaxsentan; Randomized controlled trial; Meta-analysis
Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension
Keywords: بوسنتان; Pulmonary hypertension; Endothelin-1 antagonists; Right ventricular function; BosentanHipertensão pulmonar; Antagonistas da endotelina-1; Função ventricular direita; Bosentan
Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells
Keywords: بوسنتان; Bosentan; Ambrisentan; Sildenafil; Tadalafil; Induction;
Une prescription d’antagoniste des récepteurs à l’endothéline
Keywords: بوسنتان; Bosentan; Bronchopneumopathie chronique obstructive; Hypertension artérielle pulmonaire secondaire; Insuffisance respiratoire chronique obstructiveBosentan; Chronic obstructive bronchopneumopathy; Chronic obstructive respiratory disease; Secondary pulmona
Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease
Keywords: بوسنتان; Bosentan; Congenital heart disease; Pulmonary hypertensionBosentan; Cardiopatia congénita; Hipertensão pulmonar
Long-term effect of bosentan in pulmonary hypertension associated with complex congenital heart disease
Keywords: بوسنتان; Bosentan; Congenital heart disease; Pulmonary hypertensionBosentan; Cardiopatia congénita; Hipertensão pulmonar
ESI-MSn and LC–ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC–UV method
Keywords: بوسنتان; Bosentan; Forced degradation; Mass fragmentation; Validation; Stability-indicating
Long-Term Effect of Bosentan Therapy on Cardiac Function and Symptomatic Benefits in Adult Patients With Eisenmenger Syndrome
Keywords: بوسنتان; Bosentan; Eisenmenger syndrome; myocardial performance index; long-axis function
Changes in Exercise Capacity and Cardiac Performance in a Series of Patients with Eisenmenger's Syndrome Transitioned from Selective to Dual Endothelin Receptor Antagonist
Keywords: بوسنتان; Pulmonary hypertension; Endothelin; Magnetic resonance imaging; Exercise capacity; 6 Minute walk test; Bosentan; Sitaxsentan; Eisenmenger's syndrome
Development of an SPE-LC-MS/MS method for simultaneous quantification of bosentan and its active metabolite hydroxybosentan in human plasma to support a bioequivalence study
Keywords: بوسنتان; Bosentan; Hydroxybosentan; LC-MS/MS; Human plasma; Sensitive; Incurred sample reanalysis;
Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention
Keywords: بوسنتان; alkali; bosentan; diet; eplerenone; microdialysis; valsartan;